Social Pulse: Abiomed Inc (ABMD.O)
ABMD.O on Nasdaq
Price Change (% chg)
- Abiomed: An Excellent Opportunity For Growth Seeking Investors
- Abiomed's CEO Discusses F2Q2014 Results - Earnings Call Transcript
- Stereotaxis: A Good Opportunity For Risk-Tolerant Investors
- 3 Rising Stars in the Medical Device Industry
- Affymetrix: A Multi-Bagger Turnaround Story
- Abiomed's CEO Discusses F1Q2014 (Qtr End 6/30/13) Results - Earnings Call Transcript
- Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline in the Class Action Lawsuit AgainstAbiomed, Inc.
- United Natural Foods Set to Join the S&P MidCap 400; Abiomed & Ixia to Join S&P SmallCap 600
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In ABIOMED, Inc. To Contact The Firm
- Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Abiomed, Inc.
- Investor Alert: Following Food and Drug Administration Panel Vote, Hagens Berman Reminds Abiomed, Inc. Investors of Jan. 15, 2013, Lead Plaintiff Deadline in Class-Action Lawsuit